SCHEMBL21546530

SCHEMBL21546530

C=CCc1cc(Cl)ccc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 1/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.47
ALDH1A1 P00352 6/20 0.46
CYP3A4 P08684 4/20 0.46
TSHR P16473 3/20 0.46
ALOX15 P16050 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 4/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 5/20 0.38
LMNA P02545 3/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 2/20 0.38
ALOX12 P18054 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
GABRA1 P14867 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454406 0.81 GABRA1 (0.41) ALDH1A1CYP3A4ALOX15TDP1MAPT
SCHEMBL31290769 0.81 GABRA1 (0.41) ALDH1A1CYP3A4ALOX15TDP1MAPT
SCHEMBL4647358 0.80 CYP3A4 (0.46) PTGDRPTGDR2ALDH1A1CYP3A4TSHR
SCHEMBL15066541 0.79 PTGDR (0.50) PTGDRPTGDR2ALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL6307100 0.79 GABRA1 (0.39) ALDH1A1CYP3A4ALOX15TDP1MAPT
SCHEMBL5338575 0.79 GABRA1 (0.59) ALDH1A1CYP3A4TSHRALOX15TDP1
SCHEMBL1768780 0.78 XDH (0.48) ALDH1A1CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL15322058 0.77 CYP3A4 (0.43) ALDH1A1CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL775187 0.77 CYP3A4 (0.52) ALDH1A1CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL671144 0.77 PTGDR (0.40) PTGDRPTGDR2ALDH1A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055287-B1 NON-PLATINUM-BASED ANTI-CANCER COMPOUNDS FOR USE IN TARGETED CHEMOTHERAPY LU QING BIN (CA) 2019-11-06 EP disclosed